Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
October 29, 2019
Patent Application Number
15567838
Date Filed
April 20, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present disclosure relates to compositions comprising inhibitors of human histone methyltransferase EZH2 and one or more other therapeutic agents (such as tyrosine kinase inhibitors or VEGF/VEGFR inhibitors), particularly anticancer agents such as sunitinib, and methods of combination therapy for administering to subjects in need thereof for the treatment of cancer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.